Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana
Centers for Disease Control and Prevention · Centers for Disease Control and Prevention · +5 more institutions
Abstract
Preexposure prophylaxis with antiretroviral agents has been shown to reduce the transmission of human immunodeficiency virus (HIV) among men who have sex with men; however, the efficacy among heterosexuals is uncertain.
We randomly assigned HIV-seronegative men and women to receive either tenofovir disoproxil fumarate and emtricitabine (TDF-FTC) or matching placebo once daily. Monthly study visits were scheduled, and participants received a comprehensive package of prevention services, including HIV testing, counseling on adherence to medication, management of sexually transmitted infections, monitoring for adverse events, and individualized counseling on risk reduction; bone mineral density testing was performed semiannually in a subgroup of participants.
Citation impact
- FWCI
- 100.80
- Percentile
- 100%
- References
- 12
Authors
24Topics & keywords
- Medicine
- Emtricitabine
- Placebo
- Resistance mutation
- Adverse effect
- Pre-exposure prophylaxis
- Internal medicine
- Nausea
- Good health and well-being